Literature DB >> 17545949

Role of p38 mitogen-activated protein kinase on cardiac dysfunction after hemorrhagic shock in rats.

Hiroaki Sato1, Toshiko Tanaka, Kentaro Kasai, Toshiro Kita, Noriyuki Tanaka.   

Abstract

Cardiac dysfunction is a well-known complication of hemorrhagic shock as a consequence of local inflammatory response. Several studies have indicated that p38 mitogen-activated protein kinase (MAPK) is a key mediator in organ dysfunction that is associated with the inflammatory state through the activation of proinflammatory cytokines such as TNF-alpha and IL-1beta. Whether the same applies to cardiac dysfunction after hemorrhagic shock has not been clearly determined. Therefore, in this study, the role of p38 MAPK on cardiac dysfunction after hemorrhagic shock was studied up to 5 h after a hemorrhage using FR167653, a specific inhibitor of p38 MAPK phosphorylation. The p38 MAPK phosphorylation, the cardiac mRNA expressions of TNF-alpha and IL-1beta, and intracardiac serum concentrations of each cytokine and creatine phosphokinase-MB isozyme increased after a hemorrhage. Activated neutrophil accumulation in the heart, histological inflammation-related injuries, and frequent ventricular arrhythmia were observed in the late phase after hemorrhagic shock. FR167653 inhibited these hemorrhagic changes except the induction of the primary hypotensive state. These results demonstrate that p38 MAPK phosphorylation in hemorrhagic shock plays an important role in the cardiac expression of the proinflammatory cytokines and in the development of cardiac dysfunction relative to the inflammatory responses.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17545949     DOI: 10.1097/SHK.0b013e3180326e3d

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  9 in total

1.  A nonerythropoietic peptide that mimics the 3D structure of erythropoietin reduces organ injury/dysfunction and inflammation in experimental hemorrhagic shock.

Authors:  Nimesh S A Patel; Kiran K Nandra; Michael Brines; Massimo Collino; Ws Fred Wong; Amar Kapoor; Elisa Benetti; Fera Y Goh; Roberto Fantozzi; Anthony Cerami; Christoph Thiemermann
Journal:  Mol Med       Date:  2011-05-13       Impact factor: 6.354

2.  Stimulation of A2B adenosine receptors protects against trauma-hemorrhagic shock-induced lung injury.

Authors:  Balázs Koscsó; Alexey Trepakov; Balázs Csóka; Zoltán H Németh; Pál Pacher; Holger K Eltzschig; György Haskó
Journal:  Purinergic Signal       Date:  2013-04-13       Impact factor: 3.765

3.  Loss of cardiolipin leads to longevity defects that are alleviated by alterations in stress response signaling.

Authors:  Jingming Zhou; Quan Zhong; Guiling Li; Miriam L Greenberg
Journal:  J Biol Chem       Date:  2009-04-28       Impact factor: 5.157

4.  A quantitative study of lung dysfunction following haemorrhagic shock in rats.

Authors:  Hiroaki Sato; Toshiko Tanaka; Toshiro Kita; Noriyuki Tanaka
Journal:  Int J Exp Pathol       Date:  2009-12-22       Impact factor: 1.925

Review 5.  Fluid resuscitation: past, present, and the future.

Authors:  Heena P Santry; Hasan B Alam
Journal:  Shock       Date:  2010-03       Impact factor: 3.454

6.  Effects of different resuscitation fluids on pulmonary expression of aquaporin1 and aquaporin5 in a rat model of uncontrolled hemorrhagic shock and infection.

Authors:  Ju Gao; Luojing Zhou; Yali Ge; Shunyan Lin; Jin Du
Journal:  PLoS One       Date:  2013-05-31       Impact factor: 3.240

7.  The effect of p38 mitogen-activated protein kinase activation on inflammatory liver damage following hemorrhagic shock in rats.

Authors:  Hiroaki Sato; Toshiko Tanaka; Noriyuki Tanaka
Journal:  PLoS One       Date:  2012-01-09       Impact factor: 3.240

Review 8.  Protein Kinases as Drug Development Targets for Heart Disease Therapy.

Authors:  Naranjan S Dhalla; Alison L Müller
Journal:  Pharmaceuticals (Basel)       Date:  2010-07-05

9.  Hypotheses about sub-optimal hydration in the weeks before coronavirus disease (COVID-19) as a risk factor for dying from COVID-19.

Authors:  Jodi D Stookey; Prasanna K R Allu; Dorothee Chabas; David Pearce; Florian Lang
Journal:  Med Hypotheses       Date:  2020-09-02       Impact factor: 1.538

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.